Craif present results of urine-based urothelial cancer detection at the American Association of Cancer Research (AACR) Annual Meeting 2021

Craif R&D team, Dr. Takayama and his colleagues presented the results of their research at the AACR Annual Meeting 2021.
This research result shows that urothelial cancer can be detected with high accuracy by capturing microRNAs in urine using our nanowire device and analyzing with qPCR.

For more information about this research, please refer to the original poster presented at the congress.